Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Willem A van Gool

Showing results (11-20 of 139) with videos related to

Pageof 14
Sort By:
Journal of Alzheimer'S Disease : JAD|February 3, 2012
Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairmentBen Schmand, Piet Eikelenboom, Willem A van Gool, et al.
Age and Ageing|September 21, 2007
Cholinesterase inhibitors in dementia: yes, no, or maybe?Afina W Lemstra, Edo Richard, Willem A van Gool
Gerontology|November 29, 2002
The cholinergic deficiency syndrome and its therapeutic implicationsAfina W Lemstra, Piet Eikelenboom, Willem A van Gool
Lancet (London, England)|March 2, 2010
Systemic infection and delirium: when cytokines and acetylcholine collideWillem A van Gool, Diederik van de Beek, Piet Eikelenboom
Alzheimer Disease and Associated Disorders|June 27, 2008
Revising the ADAS-cog for a more accurate assessment of cognitive impairmentHans Wouters, Willem A van Gool, Ben Schmand, et al.
Current Drug Targets. CNS and Neurological Disorders|June 25, 2005
The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implicationsAnnemieke J M Rozemuller, Willem A van Gool, Piet Eikelenboom
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Vascular risk factors as treatment target to prevent cognitive declineEdo Richard, Eric P Moll van Charante, Willem A van Gool
Stroke|January 9, 2010
Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) studyEdo Richard, Alida A Gouw, Philip Scheltens, et al.
BMJ Open|June 25, 2013
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy studyEdo Richard, Ben A Schmand, Piet Eikelenboom, et al.
Journal of the American Geriatrics Society|June 2, 2009
Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trialEdo Richard, Roy Kuiper, Marcel G W Dijkgraaf, et al.
Pageof 14

Showing results (11-20 of 139) with videos related to

Sort By:
Pageof 14
Journal of Alzheimer'S Disease : JAD|February 3, 2012
Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairmentBen Schmand, Piet Eikelenboom, Willem A van Gool, et al.
Age and Ageing|September 21, 2007
Cholinesterase inhibitors in dementia: yes, no, or maybe?Afina W Lemstra, Edo Richard, Willem A van Gool
Gerontology|November 29, 2002
The cholinergic deficiency syndrome and its therapeutic implicationsAfina W Lemstra, Piet Eikelenboom, Willem A van Gool
Lancet (London, England)|March 2, 2010
Systemic infection and delirium: when cytokines and acetylcholine collideWillem A van Gool, Diederik van de Beek, Piet Eikelenboom
Alzheimer Disease and Associated Disorders|June 27, 2008
Revising the ADAS-cog for a more accurate assessment of cognitive impairmentHans Wouters, Willem A van Gool, Ben Schmand, et al.
Current Drug Targets. CNS and Neurological Disorders|June 25, 2005
The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implicationsAnnemieke J M Rozemuller, Willem A van Gool, Piet Eikelenboom
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Vascular risk factors as treatment target to prevent cognitive declineEdo Richard, Eric P Moll van Charante, Willem A van Gool
Stroke|January 9, 2010
Vascular care in patients with Alzheimer disease with cerebrovascular lesions slows progression of white matter lesions on MRI: the evaluation of vascular care in Alzheimer's disease (EVA) studyEdo Richard, Alida A Gouw, Philip Scheltens, et al.
BMJ Open|June 25, 2013
MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer's disease in patients with mild cognitive impairment: a diagnostic accuracy studyEdo Richard, Ben A Schmand, Piet Eikelenboom, et al.
Journal of the American Geriatrics Society|June 2, 2009
Vascular care in patients with Alzheimer's disease with cerebrovascular lesions-a randomized clinical trialEdo Richard, Roy Kuiper, Marcel G W Dijkgraaf, et al.
Pageof 14